Arch Biopartners Inc.
ACHFF
$0.42
$0.0720.91%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.78% | 28.07% | 63.49% | 11.92% | -35.19% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 823.88% | 25.51% | -108.69% | 326.12% | -80.16% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 60.80% | 44.26% | 34.52% | 36.21% | -102.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -76.72% | -82.04% | 43.10% | -70.29% | -44.77% |
| Total Debt Repaid | -136.26% | -128.62% | -2.94% | 77.58% | 81.02% |
| Issuance of Common Stock | -14.46% | 3.05% | -8.32% | 79.32% | 613.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.73% | -40.55% | 0.37% | 33.40% | 322.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9,471.88% | 80.56% | 99.93% | 108.94% | 100.62% |